Ensysce Biosciences Announces Resignation of Director Curtis Rosebraugh

On April 3, 2026, Ensysce Biosciences, Inc. reported that Dr. Curtis Rosebraugh resigned from the company's Board of Directors, effective April 1, 2026. Prior to his resignation, Dr. Rosebraugh served as a member of the Nominating and Corporate Governance Committee. According to the resignation notice filed as Exhibit 17, his departure was not due to any disagreement with the company, its management, the Board, or any committee thereof. The filing does not name a successor for the vacancy on the Board or the Nominating and Corporate Governance Committee at this time. The company is listed on the Nasdaq Stock Market under the symbol ENSC. No other material corporate changes or clinical updates were disclosed in this report.